Dabrafenib, trade name Tafinlar, is a drug for the treatment of cancers associated with a mutated version of the gene BRAF - especially skin cancer. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth. Dabrafenib has clinical activity with a safety profile in patients with BRAF(V600)-mutated metastatic melanoma.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TPG17572341
Source:
達志影像
Authorization Type:
RF
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
No
Right to Privacy:
No
Same folder images: